Iteos Therapeutics Investor Relations Material

Iteos Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of a new generation of immuno-oncology therapeutics for patients living with cancer. The company is engaged in pioneering the development of highly differentiated immunotherapies, including two clinical-stage programs targeting novel, validated immuno-oncology pathways. These efforts aim to advance the treatment landscape for cancer patients by focusing on innovative therapeutic approaches that harness the body's immune system to fight cancer more effectively. Iteos Therapeutics is headquartered in Watertown, MA, and its shares are listed on the NASDAQ.